bupivacaine
bupivacaine is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including EXPAREL. Available dosage form: injection, suspension, liposomal.
Drug details
- Generic Name
- bupivacaine
- Brand Names
- EXPAREL
- Application Number
- NDA022496
- Sponsor
- Pacira Pharmaceuticals, Inc.
- NDC Codes
- 5
- Dosage Forms
- INJECTION, SUSPENSION, LIPOSOMAL
- Routes
- INFILTRATION
- Active Ingredients
- BUPIVACAINE
Indications and Usage
1 INDICATIONS AND USAGE EXPAREL is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older Regional analgesia via an interscalene brachial plexus nerve block in adults Regional analgesia via a sciatic nerve block in the popliteal fossa in adults Regional analgesia via an adductor canal block in adults EXPAREL contains bupivacaine, an amide local anesthetic, and is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older ( 1 ). Regional analgesia via an interscalene brachial plexus nerve block in adults ( 1 ). Regional analgesia via a sciatic nerve block in the popliteal fossa in adults ( 1 ). Regional analgesia via an adductor canal block in adults ( 1 ). Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block. Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block.